Sustained release of heparin from polymeric particles for inhibition of human vascular smooth muscle cell proliferation

This publication has 37 references indexed in Scilit:

• Platelet-Derived Growth Factor-BB, Insulin-like Growth Factor-I, and Phorbol Ester Activate Different Signaling Pathways for Stimulation of Vascular Smooth Muscle Cell Migration
  Experimental Cell Research, 1998
• Heparin immobilized on proteins usable for arterial prosthesis coating: Growth inhibition of smooth-muscle cells
  Journal of Biomedical Materials Research, 1998
• Heparin inhibits thrombin-induced mitogen-activated protein kinase signaling in arterial smooth muscle cells
  Journal of Vascular Surgery, 1998
• Different Effects of Thrombin Receptor Activation on Endothelium and Smooth Muscle Cells of Human Coronary Bypass Vessels
  Circulation, 1997
• Antisense Oligonucleotide Inhibition of PDGFR-β Receptor Subunit Expression Directs Suppression of Intimal Thickening
  Circulation, 1997
• The Intima
  Circulation Research, 1995
• Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Results of the randomized, double-blind STARC study. Studio Trapidil versus Aspirin nella Restenosi Coronarica.
  Circulation, 1994
• Antithrombin III inhibits thrombin-induced proliferation in human arterial smooth muscle cells.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
• The pathogenesis of atherosclerosis: a perspective for the 1990s
  Nature, 1993
• Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor.
  Proceedings of the National Academy of Sciences, 1991